Results 381 to 390 of about 1,467,646 (404)
Some of the next articles are maybe not open access.
Bispecific antibodies rise again
Nature Reviews Drug Discovery, 2014Amgen's blinatumomab is setting the stage for a bispecific revival, enabled by new formats that may solve the field's long-standing problems.
openaire +3 more sources
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel+2 more
exaly
Avidity in antibody effector functions and biotherapeutic drug design
Nature Reviews Drug Discovery, 2022Simone C Oostindie+2 more
exaly
Bispecific Monoclonal Antibodies [PDF]
openaire +1 more source
Hodgkin lymphoma: A review and update on recent progress
Ca-A Cancer Journal for Clinicians, 2018Satish Shanbhag, Richard F Ambinder
exaly
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Nature, 2020Alexander Muik+2 more
exaly
Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back
Ca-A Cancer Journal for Clinicians, 2014Giada Bianchi, Federico Gago
exaly